T&R Biofab Co., Ltd. (KOSDAQ: 246710)

T&R Biofab Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,383	20,228	35,122	23,664	23,279	4,724
Short-Term Investments	7,000	22,000	101.83	34,501	13,600	17,000
Trading Asset Securities	9,212	9,519	5,199	-	-	-
Cash & Short-Term Investments	22,596	51,747	40,423	58,166	36,879	21,724
Cash Growth	-21.82%	28.01%	-30.50%	57.72%	69.76%	-24.65%
Accounts Receivable	38.62	1,476	1,228	975.42	563.54	156.8
Other Receivables	-	612.79	702.59	427.46	597.67	381.2
Receivables	38.62	2,088	1,931	1,403	1,161	538
Inventory	2,531	2,478	2,840	3,476	3,579	424.42
Prepaid Expenses	-	374	412.33	140.69	148.35	79.88
Other Current Assets	4,427	871.45	1,229	8,121	1,067	111.15
Total Current Assets	29,592	57,558	46,835	71,306	42,834	22,877
Property, Plant & Equipment	35,827	34,836	20,287	10,996	2,616	1,893
Long-Term Investments	2,247	2,996	4,299	3,396	700	557.17
Other Intangible Assets	937.31	831.24	850.36	804.07	719.78	333.32
Other Long-Term Assets	3,520	3,595	3,668	9,006	1,636	1,427
Total Assets	72,123	99,816	75,938	95,508	48,505	27,088
Accounts Payable	21.35	13.31	14.49	-	3.09	66.98
Accrued Expenses	394.11	362.23	118.06	106.61	110.73	72.81
Short-Term Debt	19,601	28,299	13,848	-	-	-
Current Portion of Leases	794.78	1,019	516.4	826.8	446.97	475.1
Current Unearned Revenue	-	149.35	94.74	-	41.34	63.01
Other Current Liabilities	10,822	21,106	14,511	737.73	607.22	221.6
Total Current Liabilities	31,633	50,949	29,102	1,671	1,209	899.5
Long-Term Debt	16,200	16,200	6,200	13,727	-	-
Long-Term Leases	292.72	503.38	512.65	646.8	497.87	649.92
Other Long-Term Liabilities	907.31	966.07	859.83	27,030	506.05	465.83
Total Liabilities	49,186	68,619	36,675	43,075	2,453	2,330
Common Stock	10,773	10,762	10,597	5,170	4,215	4,174
Additional Paid-In Capital	145,367	145,327	143,454	142,580	65,668	39,913
Retained Earnings	-139,244	-130,518	-116,847	-106,702	-25,657	-20,049
Comprensive Income & Other	6,041	5,627	2,059	1,059	829.8	718.91
Total Common Equity	22,938	31,197	39,263	42,107	45,056	24,757
Shareholders' Equity	22,938	31,197	39,263	52,433	46,052	24,757
Total Liabilities & Equity	72,123	99,816	75,938	95,508	48,505	27,088
Total Debt	36,888	46,021	21,077	15,201	944.84	1,125
Net Cash (Debt)	-14,292	5,725	19,347	42,965	35,934	20,599
Net Cash Growth	-	-70.41%	-54.97%	19.57%	74.45%	-28.55%
Net Cash Per Share	-668.38	270.01	928.31	2415.96	4289.45	2481.32
Filing Date Shares Outstanding	21.72	21.52	21.19	20.68	16.86	16.7
Total Common Shares Outstanding	21.72	21.52	21.19	20.68	16.86	16.7
Working Capital	-2,040	6,609	17,732	69,635	41,625	21,978
Book Value Per Share	1055.95	1449.43	1852.51	2036.13	2672.07	1482.88
Tangible Book Value	22,000	30,366	38,413	41,303	44,336	24,424
Tangible Book Value Per Share	1012.80	1410.81	1812.39	1997.25	2629.39	1462.91
Land	9,745	9,745	7,511	7,511	-	-
Buildings	3,963	4,072	-	-	-	-
Machinery	3,442	4,535	2,968	2,630	1,896	1,011
Construction In Progress	17,201	-	10,475	169.1	39.94	-

Source: S&P Capital IQ. Standard template. Financial Sources.